X-80022435-G-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001109878.2(TBX22):āc.166G>Cā(p.Glu56Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000931 in 1,181,665 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001109878.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBX22 | NM_001109878.2 | c.166G>C | p.Glu56Gln | missense_variant | 2/9 | ENST00000373296.8 | NP_001103348.1 | |
TBX22 | NM_016954.2 | c.166G>C | p.Glu56Gln | missense_variant | 1/8 | NP_058650.1 | ||
TBX22 | NM_001109879.2 | c.-191G>C | 5_prime_UTR_variant | 2/9 | NP_001103349.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBX22 | ENST00000373296.8 | c.166G>C | p.Glu56Gln | missense_variant | 2/9 | 5 | NM_001109878.2 | ENSP00000362393 | P1 | |
TBX22 | ENST00000373294.8 | c.166G>C | p.Glu56Gln | missense_variant | 1/8 | 1 | ENSP00000362390 | P1 | ||
TBX22 | ENST00000476373.1 | n.287G>C | non_coding_transcript_exon_variant | 2/2 | 3 | |||||
TBX22 | ENST00000626498.2 | c.166G>C | p.Glu56Gln | missense_variant, NMD_transcript_variant | 2/9 | 2 | ENSP00000487527 |
Frequencies
GnomAD3 genomes AF: 0.00000896 AC: 1AN: 111561Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33731
GnomAD3 exomes AF: 0.0000148 AC: 2AN: 134729Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 42401
GnomAD4 exome AF: 0.00000934 AC: 10AN: 1070104Hom.: 0 Cov.: 31 AF XY: 0.00000288 AC XY: 1AN XY: 347238
GnomAD4 genome AF: 0.00000896 AC: 1AN: 111561Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33731
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2021 | The c.166G>C (p.E56Q) alteration is located in exon 2 (coding exon 1) of the TBX22 gene. This alteration results from a G to C substitution at nucleotide position 166, causing the glutamic acid (E) at amino acid position 56 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at